34 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Author: Lisa Levin | January 15, 2020 09:10am

Gainers

OrganiGram Holdings, Inc. (NASDAQ:OGI) shares increased by 26.9% to $2.74 during Wednesday's pre-market session. According to the most recent rating by Raymond James, on January 09, the current rating is at Market Perform.
Rockwell Medical, Inc. (NASDAQ:RMTI) stock rose 23.3% to $2.86. The most recent rating by Piper Jaffray, on November 12, is at Overweight, with a price target of $6.00.
Oncolytics Biotech, Inc. (NASDAQ:ONCY) stock increased by 16.7% to $3.35.
Clovis Oncology, Inc. (NASDAQ:CLVS) stock moved upwards by 15.6% to $10.29. The most recent rating by Evercore ISI Group, on November 19, is at In-Line, with a price target of $8.00.
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) stock moved upwards by 14.8% to $29.12. The most recent rating by JP Morgan, on January 15, is at Overweight, with a price target of $30.00.
Durect, Inc. (NASDAQ:DRRX) stock increased by 13.4% to $2.79. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.
Neovasc, Inc. (NASDAQ:NVCN) shares increased by 13.3% to $3.50. The most recent rating by H.C. Wainwright, on October 24, is at Buy, with a price target of $9.00.
Beyond Air, Inc. (NASDAQ:XAIR) shares surged 8.8% to $6.30. The most recent rating by Oppenheimer, on October 22, is at Outperform, with a price target of $9.00.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) shares increased by 7.1% to $3.00. The most recent rating by H.C. Wainwright, on December 23, is at Buy, with a price target of $18.00.
Tilray, Inc. (NASDAQ:TLRY) shares surged 5.4% to $22.36. The most recent rating by B of A Securities, on January 13, is at Neutral, with a price target of $18.00.
ASLAN Pharmaceuticals, Inc. (NASDAQ:ASLN) shares increased by 5.2% to $2.61. The most recent rating by H.C. Wainwright, on December 10, is at Buy, with a price target of $5.00.
OpGen, Inc. (NASDAQ:OPGN) stock surged 4.3% to $1.69.
Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) stock rose 4.2% to $0.28. The most recent rating by Maxim Group, on October 23, is at Buy, with a price target of $1.00.
HEXO, Inc. (NYSE:HEXO) shares surged 3.8% to $1.65.
Aurora Cannabis, Inc. (NYSE:ACB) shares moved upwards by 3.6% to $1.85. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) stock moved upwards by 3.2% to $4.24.
Aphria, Inc. (NYSE:APHA) shares moved upwards by 3.0% to $5.13. According to the most recent rating by B of A Securities, on January 13, the current rating is at Neutral.
ContraFect, Inc. (NASDAQ:CFRX) stock rose 2.5% to $1.26.
Microbot Medical, Inc. (NASDAQ:MBOT) stock surged 2.2% to $11.85. The most recent rating by H.C. Wainwright, on January 13, is at Buy, with a price target of $26.00.
CannTrust Holdings, Inc. (NYSE:CTST) stock rose 1.8% to $1.13.
Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares rose 1.7% to $2.38. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
Canopy Growth, Inc. (NYSE:CGC) stock surged 1.7% to $24.25. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
Novo Nordisk, Inc. (NYSE:NVO) stock rose 1.7% to $60.61. The most recent rating by Ladenburg Thalmann, on January 06, is at Buy, with a price target of $15.00.

Losers

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) shares plummeted 15.8% to $15.25 during Wednesday's pre-market session.
Nektar Therapeutics, Inc. (NASDAQ:NKTR) stock plummeted 14.7% to $23.84. The most recent rating by JP Morgan, on November 13, is at Neutral, with a price target of $28.00.
Midatech Pharma, Inc. (NASDAQ:MTP) stock decreased by 10.0% to $0.90.
Adaptimmune Therapeutics, Inc. (NASDAQ:ADAP) shares plummeted 5.9% to $3.80.
Acasti Pharma, Inc. (NASDAQ:ACST) shares fell 4.3% to $0.90. The most recent rating by B. Riley FBR, on January 13, is at Neutral, with a price target of $2.00.
Genetic Technologies, Inc. (NASDAQ:GENE) stock decreased by 3.9% to $4.23.
La Jolla Pharmaceutical, Inc. (NASDAQ:LJPC) shares plummeted 3.6% to $8.52. According to the most recent rating by H.C. Wainwright, on November 26, the current rating is at Neutral.
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) shares fell 2.7% to $3.60.
Cassava Sciences, Inc. (NASDAQ:SAVA) stock decreased by 2.1% to $7.36. The most recent rating by H.C. Wainwright, on December 06, is at Buy, with a price target of $6.00.
Dare Bioscience, Inc. (NASDAQ:DARE) stock plummeted 1.5% to $1.35.
UnitedHealth Group, Inc. (NYSE:UNH) stock plummeted 1.2% to $284.50. The most recent rating by Credit Suisse, on January 08, is at Outperform, with a price target of $330.00.